Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6NJ0

Wild-type E. coli MenE with bound m phenylether-linked analogue of OSB-AMS

Summary for 6NJ0
Entry DOI10.2210/pdb6nj0/pdb
Descriptor2-succinylbenzoate--CoA ligase, 5'-O-{3-[3-(2-carboxyphenyl)-3-oxopropyl]phenyl}adenosine (3 entities in total)
Functional Keywordsmene, e. coli, menaquinone, ligase
Biological sourceEscherichia coli (strain K12)
Total number of polymer chains1
Total formula weight50755.97
Authors
Si, Y.,Yin, Y.,French, J.B.,Tonge, P.J. (deposition date: 2019-01-02, release date: 2019-04-10, Last modification date: 2024-03-13)
Primary citationEvans, C.E.,Si, Y.,Matarlo, J.S.,Yin, Y.,French, J.B.,Tonge, P.J.,Tan, D.S.
Structure-Based Design, Synthesis, and Biological Evaluation of Non-Acyl Sulfamate Inhibitors of the Adenylate-Forming Enzyme MenE.
Biochemistry, 58:1918-1930, 2019
Cited by
PubMed Abstract: N-Acyl sulfamoyladenosines (acyl-AMS) have been used extensively to inhibit adenylate-forming enzymes that are involved in a wide range of biological processes. These acyl-AMS inhibitors are nonhydrolyzable mimics of the cognate acyl adenylate intermediates that are bound tightly by adenylate-forming enzymes. However, the anionic acyl sulfamate moiety presents a pharmacological liability that may be detrimental to cell permeability and pharmacokinetic profiles. We have previously developed the acyl sulfamate OSB-AMS (1) as a potent inhibitor of the adenylate-forming enzyme MenE, an o-succinylbenzoate-CoA (OSB-CoA) synthetase that is required for bacterial menaquinone biosynthesis. Herein, we report the use of computational docking to develop novel, non-acyl sulfamate inhibitors of MenE. A m-phenyl ether-linked analogue (5) was found to be the most potent inhibitor (IC = 8 μM; K = 244 nM), and its X-ray co-crystal structure was determined to characterize its binding mode in comparison to the computational prediction. This work provides a framework for the development of potent non-acyl sulfamate inhibitors of other adenylate-forming enzymes in the future.
PubMed: 30912442
DOI: 10.1021/acs.biochem.9b00003
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.83 Å)
Structure validation

248335

PDB entries from 2026-01-28

PDB statisticsPDBj update infoContact PDBjnumon